How can clinical trials be made above reproach? How can a healthcare professional best interpret the results of clinical trials? Dr. Steven Nissen, chairman of the department of cardiovascular medicine at the Cleveland Clinic and past-president of the American College of Cardiology, joins Host Dr. Martin A. Samuels to discuss these and other topics
Making Clinical Trials More Relevant
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
How can clinical trials be made above reproach? How can a healthcare professional best interpret the results of clinical trials? Dr. Steven Nissen, chairman of the department of cardiovascular medicine at the Cleveland Clinic and past-president of the American College of Cardiology, joins Host Dr. Martin A. Samuels to discuss these and other topics
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Love Story: Lipid Education for Women’s Heart Health
Personalizing Care Within the RCC Treatment Paradigm
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?